beta-lactams has been researched along with Hematologic Malignancies in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Albasanz-Puig, A; Arnan, M; Batlle, M; Carmona-Torre, F; Carratalà, J; Del Pozo, JL; Garcia-Vidal, C; Gudiol, C; Huguet, M; Laporte-Amargos, J; Muñoz, C; Padullés, A; Parody, R; Puerta-Alcalde, P; Rigo-Bonnin, R; Sureda, A; Tebé, C; Tubau, F; Videla, S | 1 |
| McCarthy, KL; Paterson, DL | 1 |
| Cluzet, V; Fadugba, O; Hamilton, K; Huang, KG | 1 |
| Amit, O; Avivi, I; Ben-Ami, R; Halavy, Y; Katchman, E; Kor, S; Paran, Y; Ram, R; Yachini, B | 1 |
| Bergeron, A; Derouin, F; Menotti, J; Porcher, R; Raffoux, E; Ribaud, P; Sulahian, A; Touratier, S | 1 |
| Maraki, S; Papadakis, IS | 1 |
| Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Ohtake, S; Sakagami, M; Takahashi, H; Takei, M; Uchino, Y | 1 |
| Abdala, E; Akova, M; Álvarez, R; Cano, A; Carratalà, J; Cervera, C; Clemente, WT; Freifeld, A; Gómez, L; Gottlieb, T; Gudiol, C; Gurguí, M; Herrera, F; Maestro-de la Calle, G; Manzur, A; Martín-Dávila, P; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Royo-Cebrecos, C; Ruiz-Camps, I; Sukiennik, TC; Tebe, C | 1 |
| Harada, H; Kawakami, K; Maruyama, I; Mogi, A; Narahara, S; Nishi, JI; Yoshinaga, M | 1 |
1 review(s) available for beta-lactams and Hematologic Malignancies
| Article | Year |
|---|---|
Rothia mucilaginosa pneumonia: a literature review.
Topics: Anti-Bacterial Agents; beta-Lactams; Hematologic Neoplasms; Humans; Immunocompetence; Immunocompromised Host; Lung; Male; Micrococcaceae; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography; Vancomycin | 2015 |
3 trial(s) available for beta-lactams and Hematologic Malignancies
| Article | Year |
|---|---|
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Clinical Trials, Phase IV as Topic; Critical Care; Critical Illness; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infusions, Parenteral; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Spain; Treatment Outcome; Young Adult | 2020 |
Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Febrile Neutropenia; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2018 |
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
Topics: Adult; Aged; Anti-Infective Agents; beta-Lactams; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome | 2016 |
5 other study(ies) available for beta-lactams and Hematologic Malignancies
| Article | Year |
|---|---|
Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Retrospective Studies; Risk Factors; Tertiary Care Centers; Young Adult | 2017 |
The Impact of Reported Beta-Lactam Allergy in Hospitalized Patients With Hematologic Malignancies Requiring Antibiotics.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Drug Hypersensitivity; Female; Health Care Costs; Hematologic Neoplasms; Hospital Mortality; Hospitalization; Humans; Inpatients; Length of Stay; Male; Middle Aged; Penicillins; Retrospective Studies; Tertiary Healthcare | 2018 |
Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Topics: Anti-Bacterial Agents; Antigens, Fungal; beta-Glucans; beta-Lactams; False Positive Reactions; Galactose; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Mannans; Proteoglycans; Sensitivity and Specificity; Serum | 2014 |
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospectiv
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Superinfection | 2017 |
Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases.
Topics: Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Streptococcus | 1997 |